GlassScriptPhysician profile
Jeffrey Buncher
NPI 1255457693
$10,127.68
in general payments reported to CMS, 2019-2025
34 companies · $8,124 in 2025
The $8,124 reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $231 · 2020: $159 · 2021: $315 · 2022: $470 · 2023: $354 · 2024: $473 · 2025: $8,124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,871 · Food and Beverage: $1,817 · Travel and Lodging: $1,264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,871.00 |
| Food and Beverage | $1,817.00 |
| Travel and Lodging | $1,263.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $7,865.58 | 2019-2025 | Sublocade |
| Abbvie INC. | $515.35 | 2021-2025 | Vraylar, Ubrelvy, Qulipta |
| Lilly USA, LLC | $141.21 | 2020-2024 | Mounjaro, Zepbound, Trulicity |
| Alnylam Pharmaceuticals INC. | $121.80 | 2021-2025 | Givlaari, Onpattro |
| Exact Sciences Corporation | $114.63 | 2025 | The Cologuard Plus Collection Kit |
| Alkermes, INC. | $112.92 | 2021-2023 | Vivitrol |
| Braeburn INC. | $109.16 | 2023-2024 | Brixadi |
| Amgen INC. | $98.13 | 2019-2022 | |
| Averitas Pharma INC. | $97.19 | 2025 | Qutenza |
| Forte Bio-Pharma LLC | $77.52 | 2020-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $77.12 | 2025 | Caplyta |
| Astrazeneca Pharmaceuticals LP | $75.76 | 2023 | Breztri |
| Grt US Holding, INC. | $65.43 | 2022 | |
| Sentynl Therapeutics, INC. | $64.58 | 2019 | |
| Hikma Pharmaceuticals USA | $52.50 | 2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $50.14 | 2019-2020 | |
| Eisai INC. | $49.03 | 2020-2021 | |
| Pfizer INC. | $45.21 | 2025 | |
| Avanir Pharmaceuticals, INC. | $40.11 | 2022 | |
| Novartis Pharmaceuticals Corporation | $40.05 | 2019-2022 | |
| Biodelivery Sciences International, INC. | $36.40 | 2020-2021 | |
| Collegium Pharmaceutical, INC. | $29.51 | 2021-2022 | |
| Harmony Biosciences LLC | $27.61 | 2024 | |
| Boston Scientific Corporation | $26.12 | 2019 | |
| Organogenesis INC. | $24.37 | 2022 | |
| Novo Nordisk INC | $22.17 | 2025 | Wegovy |
| Teva Pharmaceuticals USA, INC. | $22.09 | 2022 | |
| Virtus Pharmaceuticals LLC | $21.97 | 2020 | |
| Lundbeck LLC | $21.80 | 2023 | Vyepti |
| Biohaven Pharmaceutical Holding Company LTD. | $20.43 | 2022 | |
| Nevro Corp. | $18.49 | 2024 | Senza |
| Kaleo, INC. | $17.49 | 2019 | |
| Redhill Biopharma INC. | $13.87 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $11.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Buncher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.